Insider · CIK 0001816836

Norkunas Matthew

Reports to the SEC for 2 companies · CAMBRIDGE, MA

sec.gov

Transactions

Companies

Filings

CIK

0001816836

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-08-03	OBXObsidian Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+37.7K sh	—	—	37,653
2024-10-15	GBIOGeneration Bio Co.M Exercise/Conversion	CHIEF FINANCIAL OFFICER	MExercise/Conversion	+1,674 sh	—	—	56,659
2024-10-15	GBIOGeneration Bio Co.F Tax Payment	CHIEF FINANCIAL OFFICER	FTax Payment	−492 sh	$2.42	−$1,190.64	56,167
2024-10-15	GBIOGeneration Bio Co.M Exercise/Conversion	CHIEF FINANCIAL OFFICER	MExercise/Conversion	+1,673 sh	—	—	57,840
2024-10-15	GBIOGeneration Bio Co.F Tax Payment	CHIEF FINANCIAL OFFICER	FTax Payment	−492 sh	$2.42	−$1,190.64	57,348
2024-10-15	GBIOGeneration Bio Co. · Restricted Stock UnitsM Exercise/Conversion	CHIEF FINANCIAL OFFICER	MExercise/Conversion	−1,674 sh	—	—	15,059
2024-10-15	GBIOGeneration Bio Co. · Restricted Stock UnitsM Exercise/Conversion	CHIEF FINANCIAL OFFICER	MExercise/Conversion	−1,673 sh	—	—	1,673
2024-07-15	GBIOGeneration Bio Co.M Exercise/Conversion	CHIEF FINANCIAL OFFICER	MExercise/Conversion	+1,674 sh	—	—	54,296
2024-07-15	GBIOGeneration Bio Co.F Tax Payment	CHIEF FINANCIAL OFFICER	FTax Payment	−492 sh	$2.93	−$1,441.56	53,804
2024-07-15	GBIOGeneration Bio Co.M Exercise/Conversion	CHIEF FINANCIAL OFFICER	MExercise/Conversion	+1,673 sh	—	—	55,477
2024-07-15	GBIOGeneration Bio Co.F Tax Payment	CHIEF FINANCIAL OFFICER	FTax Payment	−492 sh	$2.93	−$1,441.56	54,985
2024-07-15	GBIOGeneration Bio Co. · Restricted Stock UnitsM Exercise/Conversion	CHIEF FINANCIAL OFFICER	MExercise/Conversion	−1,674 sh	—	—	16,733
2024-07-15	GBIOGeneration Bio Co. · Restricted Stock UnitsM Exercise/Conversion	CHIEF FINANCIAL OFFICER	MExercise/Conversion	−1,673 sh	—	—	3,346
2024-04-15	GBIOGeneration Bio Co.M Exercise/Conversion	CHIEF FINANCIAL OFFICER	MExercise/Conversion	+1,674 sh	—	—	51,933
2024-04-15	GBIOGeneration Bio Co.F Tax Payment	CHIEF FINANCIAL OFFICER	FTax Payment	−492 sh	$3.70	−$1,820.4	51,441
2024-04-15	GBIOGeneration Bio Co.M Exercise/Conversion	CHIEF FINANCIAL OFFICER	MExercise/Conversion	+1,673 sh	—	—	53,114
2024-04-15	GBIOGeneration Bio Co.F Tax Payment	CHIEF FINANCIAL OFFICER	FTax Payment	−492 sh	$3.70	−$1,820.4	52,622
2024-04-15	GBIOGeneration Bio Co. · Restricted Stock UnitsM Exercise/Conversion	CHIEF FINANCIAL OFFICER	MExercise/Conversion	−1,674 sh	—	—	18,407
2024-04-15	GBIOGeneration Bio Co. · Restricted Stock UnitsM Exercise/Conversion	CHIEF FINANCIAL OFFICER	MExercise/Conversion	−1,673 sh	—	—	5,019
2024-01-15	GBIOGeneration Bio Co.M Exercise/Conversion	CHIEF FINANCIAL OFFICER	MExercise/Conversion	+7,437 sh	—	—	47,369
2024-01-15	GBIOGeneration Bio Co.F Tax Payment	CHIEF FINANCIAL OFFICER	FTax Payment	−2,577 sh	$1.91	−$4,922.07	44,792
2024-01-15	GBIOGeneration Bio Co.M Exercise/Conversion	CHIEF FINANCIAL OFFICER	MExercise/Conversion	+6,694 sh	—	—	51,486
2024-01-15	GBIOGeneration Bio Co.F Tax Payment	CHIEF FINANCIAL OFFICER	FTax Payment	−2,320 sh	$1.91	−$4,431.2	49,166
2024-01-15	GBIOGeneration Bio Co.M Exercise/Conversion	CHIEF FINANCIAL OFFICER	MExercise/Conversion	+1,674 sh	—	—	50,840
2024-01-15	GBIOGeneration Bio Co.F Tax Payment	CHIEF FINANCIAL OFFICER	FTax Payment	−581 sh	$1.91	−$1,109.71	50,259
2024-01-15	GBIOGeneration Bio Co. · Restricted Stock UnitsM Exercise/Conversion	CHIEF FINANCIAL OFFICER	MExercise/Conversion	−7,437 sh	—	—	0
2024-01-15	GBIOGeneration Bio Co. · Restricted Stock UnitsM Exercise/Conversion	CHIEF FINANCIAL OFFICER	MExercise/Conversion	−6,694 sh	—	—	20,081
2024-01-15	GBIOGeneration Bio Co. · Restricted Stock UnitsM Exercise/Conversion	CHIEF FINANCIAL OFFICER	MExercise/Conversion	−1,674 sh	—	—	6,692
2024-01-02	GBIOGeneration Bio Co. · Stock Option (right to buy)A Award	CHIEF FINANCIAL OFFICER	AAward	+161K sh	—	—	160,650
2023-12-01	GBIOGeneration Bio Co. · Stock Option (right to buy)A Award	CHIEF FINANCIAL OFFICER	AAward	+76.3K sh	—	—	76,310
2023-10-15	GBIOGeneration Bio Co.M Exercise/Conversion	CHIEF FINANCIAL OFFICER	MExercise/Conversion	+7,437 sh	—	—	40,933
2023-10-15	GBIOGeneration Bio Co.F Tax Payment	CHIEF FINANCIAL OFFICER	FTax Payment	−2,183 sh	$3.24	−$7,072.92	38,750
2023-10-15	GBIOGeneration Bio Co.M Exercise/Conversion	CHIEF FINANCIAL OFFICER	MExercise/Conversion	+1,674 sh	—	—	40,424
2023-10-15	GBIOGeneration Bio Co.F Tax Payment	CHIEF FINANCIAL OFFICER	FTax Payment	−492 sh	$3.24	−$1,594.08	39,932
2023-10-15	GBIOGeneration Bio Co. · Restricted Stock UnitsM Exercise/Conversion	CHIEF FINANCIAL OFFICER	MExercise/Conversion	−7,437 sh	—	—	7,437
2023-10-15	GBIOGeneration Bio Co. · Restricted Stock UnitsM Exercise/Conversion	CHIEF FINANCIAL OFFICER	MExercise/Conversion	−1,674 sh	—	—	8,366
2023-07-15	GBIOGeneration Bio Co.M Exercise/Conversion	CHIEF FINANCIAL OFFICER	MExercise/Conversion	+7,437 sh	—	—	33,314
2023-07-15	GBIOGeneration Bio Co.F Tax Payment	CHIEF FINANCIAL OFFICER	FTax Payment	−2,183 sh	$5.08	−$11.1K	31,131
2023-07-15	GBIOGeneration Bio Co.M Exercise/Conversion	CHIEF FINANCIAL OFFICER	MExercise/Conversion	+3,348 sh	—	—	34,479
2023-07-15	GBIOGeneration Bio Co.F Tax Payment	CHIEF FINANCIAL OFFICER	FTax Payment	−983 sh	$5.08	−$4,993.64	33,496
2023-07-15	GBIOGeneration Bio Co. · Restricted Stock UnitsM Exercise/Conversion	CHIEF FINANCIAL OFFICER	MExercise/Conversion	−7,437 sh	—	—	14,874
2023-07-15	GBIOGeneration Bio Co. · Restricted Stock UnitsM Exercise/Conversion	CHIEF FINANCIAL OFFICER	MExercise/Conversion	−3,348 sh	—	—	10,040
2023-04-15	GBIOGeneration Bio Co.M Exercise/Conversion	CHIEF FINANCIAL OFFICER	MExercise/Conversion	+7,437 sh	—	—	28,060
2023-04-15	GBIOGeneration Bio Co.F Tax Payment	CHIEF FINANCIAL OFFICER	FTax Payment	−2,183 sh	$4.50	−$9,823.5	25,877
2023-04-15	GBIOGeneration Bio Co. · Restricted Stock UnitsM Exercise/Conversion	CHIEF FINANCIAL OFFICER	MExercise/Conversion	−7,437 sh	—	—	22,311
2023-01-20	GBIOGeneration Bio Co. · Stock Option (right to buy)A Award	CHIEF FINANCIAL OFFICER	AAward	+53.6K sh	—	—	53,550
2023-01-20	GBIOGeneration Bio Co. · Restricted Stock UnitsA Award	CHIEF FINANCIAL OFFICER	AAward	+26.8K sh	—	—	26,775
2023-01-20	GBIOGeneration Bio Co. · Restricted Stock UnitsA Award	CHIEF FINANCIAL OFFICER	AAward	+13.4K sh	—	—	13,388
2023-01-15	GBIOGeneration Bio Co.M Exercise/Conversion	CHIEF FINANCIAL OFFICER	MExercise/Conversion	+7,438 sh	—	—	23,201
2023-01-15	GBIOGeneration Bio Co.F Tax Payment	CHIEF FINANCIAL OFFICER	FTax Payment	−2,578 sh	$5.10	−$13.1K	20,623

Recent filings

Accepted (ET)
Aug 54
Norkunas Matthew0001193125-26-335083
SEC(opens sec.gov)
Oct 174
Norkunas Matthew0001415889-24-025336
SEC(opens sec.gov)
Jul 174
Norkunas Matthew0001415889-24-019650
SEC(opens sec.gov)
Apr 174
Norkunas Matthew0001415889-24-011040
SEC(opens sec.gov)
Jan 174
Norkunas Matthew0001415889-24-001329
SEC(opens sec.gov)

Companies

Address

C/O OBSIDIAN THERAPEUTICS, INC. 1030 MASSACHUSETTS AVE

CAMBRIDGE, MA, 02138